Michael John Frodsham

Title: Michael John Frodsham: Innovator in Pharmaceutical Formulations

Introduction

Michael John Frodsham is a notable inventor based in Flintshire, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work primarily focuses on innovative formulations that enhance therapeutic efficacy.

Latest Patents

Among his latest patents is a formulation for Methotrexate, which is a liquid pharmaceutical composition that includes methotrexate free acid and a buffer. The pH of this composition is maintained within the range of 6.5 to 8.2, making it useful in therapy. Additionally, he has developed dosage forms that comprise a plasma kallikrein inhibitor. This invention relates to oral solid dosage forms, particularly a solid form of the compound of Formula A, along with methods for preparing these dosage forms.

Career Highlights

Throughout his career, Michael has worked with several companies, including Therakind Ltd. and Kalvista Pharmaceuticals Limited. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical sciences.

Collaborations

Michael has collaborated with notable professionals in the field, including Julie-Ann Penton and John Herman Collett. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Michael John Frodsham is a distinguished inventor whose work in pharmaceutical formulations has the potential to improve therapeutic outcomes. His innovative contributions continue to shape the landscape of medicine.